Drug repurposing and reimbursement challenges

In times of economic scrutiny, achieving reimbursement from payers and market access for new treatments is a major consideration during development and a particular concern. As David Cavalla, Founder of Numedicus wrote in his most recent blog post, "The drug regulatory system is directed towards the approval of new medicines for particular uses, based on clinical trials and other evidence …